Skip to content

PHARMACO: what changed

BE 0439.793.050NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2025 and 2026

Net result for the year
€31
2025 · €0+€31
Equity
€193,513
2025 · €193,482+€31
Cash
€93,816
2025 · €55,110+€38,706
Balance sheet total
€604,705
2025 · €578,029+€26,676

Largest movements

2025 to 2026
Assets
  • Cash +€38,706

    up €38,706 (+70.2%), from €55,110 to €93,816

    mainly Depreciation (+€26,800) and Other debts (+€20,276)

  • Stocks and contracts +€32,076

    up €32,076 (+14.3%), from €224,223 to €256,299

  • Receivables within one year -€15,399

    down €15,399 (-31.4%), from €49,038 to €33,639

    of which Trade receivables: -€16,375

  • Tangible fixed assets -€14,300

    down €14,300 (-20.2%), from €70,688 to €56,387

    of which Plant, machinery and equipment: -€10,419

  • Intangible fixed assets -€12,500

    no longer reported in 2026; in 2025 it stood at €12,500

Equity and liabilities
  • Other debts +€20,276

    up €20,276 (+13.0%), from €156,275 to €176,551

  • Trade debts +€19,594

    up €19,594 (+11.0%), from €178,253 to €197,847

  • Debts after one year -€6,750

    no longer reported in 2026; in 2025 it stood at €6,750

  • Current portion of long-term debt -€6,750

    down €6,750 (-50.0%), from €13,500 to €6,750

Income statement
  • Staff costs -€10,253

    down €10,253 (-4.1%), from €250,222 to €239,969

  • Gross operating margin -€10,251

    down €10,251 (-3.4%), from €301,939 to €291,688

Change in the result, 2025 to 2026

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2025 €0
Gross operating margin -€10,251
Staff costs +€10,253
Depreciation -€630
Other operating charges +€94
Financial income +€118
Financial charges +€117
Taxes +€330
Result 2026 €31
raises the resultlowers the result

Derived cash bridge

cash 2025 to 2026

The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€50,344
Investment +€1,862
Financing -€13,500
Cash 2025 €55,110
Net result for the year +€31
Depreciation +€26,800
Stocks and contracts -€32,076
Receivables within one year +€15,399
Smaller working-capital items +€23
Trade debts +€19,594
Tax, wage and social debts +€297
Other debts +€20,276
Investment in fixed assets (net) +€1,862
Debts after one year -€6,750
Current portion of long-term debt -€6,750
Cash 2026 €93,816
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2025 2026 Change %
Total assets 20/58 €578,029 €604,705 +€26,676 +4.6%
Fixed assets 21/28 €96,949 €68,287 -€28,662 -29.6%
Intangible fixed assets 21 €12,500 - -€12,500
Tangible fixed assets 22/27 €70,688 €56,387 -€14,300 -20.2%
Plant, machinery and equipment 23 €52,194 €41,775 -€10,419 -20.0%
Furniture and vehicles 24 €18,494 €14,612 -€3,881 -21.0%
Financial fixed assets 28 €13,762 €11,900 -€1,862 -13.5%
Current assets 29/58 €481,080 €536,418 +€55,338 +11.5%
Stocks and contracts in progress 3 €224,223 €256,299 +€32,076 +14.3%
Stocks 30/36 €224,223 €256,299 +€32,076 +14.3%
Amounts receivable within one year 40/41 €49,038 €33,639 -€15,399 -31.4%
Trade receivables 40 €26,884 €10,509 -€16,375 -60.9%
Other amounts receivable 41 €22,154 €23,130 +€976 +4.4%
Cash at bank and in hand 54/58 €55,110 €93,816 +€38,706 +70.2%
Deferred charges and accrued income 490/1 €152,709 €152,663 -€45 0.0%
Total equity and liabilities 10/49 €578,029 €604,705 +€26,676 +4.6%
Equity 10/15 €193,482 €193,513 +€31 0.0%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €131,481 €131,513 +€32 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €125,281 €125,313 +€32 0.0%
Profit (loss) carried forward 14 €0 €0 -€0 -100%
Amounts payable 17/49 €384,547 €411,192 +€26,645 +6.9%
Amounts payable after more than one year 17 €6,750 - -€6,750
Financial debts 170/4 €6,750 - -€6,750
Amounts payable within one year 42/48 €376,644 €410,060 +€33,417 +8.9%
Current portion of amounts payable after more than one year 42 €13,500 €6,750 -€6,750 -50.0%
Trade debts 44 €178,253 €197,847 +€19,594 +11.0%
Suppliers 440/4 €178,253 €197,847 +€19,594 +11.0%
Taxes, remuneration and social security 45 €28,615 €28,911 +€297 +1.0%
Taxes 450/3 €311 €712 +€400 +129%
Remuneration and social security 454/9 €28,304 €28,200 -€104 -0.4%
Other amounts payable 47/48 €156,275 €176,551 +€20,276 +13.0%
Accrued charges and deferred income 492/3 €1,154 €1,131 -€22 -1.9%
Remuneration, social security and pensions 62 €250,222 €239,969 -€10,253 -4.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €26,171 €26,800 +€630 +2.4%
Other operating charges 640/8 €748 €654 -€94 -12.6%
Gross operating margin 9900 €301,939 €291,688 -€10,251 -3.4%
Operating profit (loss) 9901 €24,798 €24,265 -€534 -2.2%
Financial income 75/76B - €118 +€118
Recurring financial income 75 - €118 +€118
Financial charges 65/66B €18,757 €18,640 -€117 -0.6%
Recurring financial charges 65 €18,757 €18,640 -€117 -0.6%
Profit (loss) for the period before taxes 9903 €6,042 €5,743 -€299 -4.9%
Income taxes 67/77 €6,041 €5,712 -€330 -5.5%
Profit (loss) for the period 9904 €0 €31 +€31 +7,969%
Profit (loss) for the period to be appropriated 9905 €0 €31 +€31 +7,969%

Value

latest balance sheet 01-01-2026 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€97,821 to €98,247

Midpoint €97,998 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €193,513
Capitalised earnings €2,129 to €2,980
Indication €97,821 to €98,247

Adjusted equity

balance sheet 01-01-2026
Equity (10/15)
€193,513
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€193,513

Capitalised earnings

net result for the year (9904)
2026
€31
2025
€0
2024
€861
2023
€1,234
2022
€4,913
Average result
€298
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€2,129 / €2,483 / €2,980

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 1 January 2025 and 1 January 2026. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.